The Potential Role of CAR T Therapy in AL Amyloidosis
A panel of expert oncologists discuss the underlying rationale and potential role for CAR T therapy in patients with AL amyloidosis.
Stay updated with breaking news from Nxc 201. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A panel of expert oncologists discuss the underlying rationale and potential role for CAR T therapy in patients with AL amyloidosis.
A panel of expert oncologists explore novel therapies using monoclonal antibodies designed to target amyloid deposit, highlighting key data from the VITAL study.
A panel of expert oncologists explore the ongoing AFFIRM-AL trial, examining birtamimab in patients diagnosed with Mayo stage IV AL amyloidosis.
A panel of expert oncologists discuss the importance of cardiac staging for patients with AL amyloidosis and it’s role in guiding overall treatment.
Faculty delve into potential challenges related to the management of patients with AL amyloidosis and cardiac involvement, discussing the associated prognostic implications.